UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy

Journal of neurology, 2022-05, Vol.269 (5), p.2403-2413

2022

Volltextzugriff (PDF)

Editorial: Autoimmune complications of modern cancer therapies

Frontiers in immunology, 2023, Vol.14, p.1357825-1357825

2023

Volltextzugriff (PDF)

Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation

Scientific reports, 2021-04, Vol.11 (1), p.8527-8527, Article 8527

2021

Volltextzugriff (PDF)

The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis

Scientific reports, 2023-08, Vol.13 (1), p.12696-12696, Article 12696

2023

Volltextzugriff (PDF)

PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy

Therapeutic advances in neurological disorders, 2021, Vol.14, p.1756286421993684-1756286421993684

2021

Volltextzugriff (PDF)

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS

Frontiers in immunology, 2020-05, Vol.11, p.1059

2020

Volltextzugriff (PDF)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics

Frontiers in neurology, 2019-08, Vol.10, p.839-839

2019

Volltextzugriff (PDF)

Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients

Cells (Basel, Switzerland), 2018-12, Vol.8 (1), p.12

2018

Volltextzugriff (PDF)

Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time

Frontiers in immunology, 2024, Vol.15, p.1298598-1298598

2024

Volltextzugriff (PDF)

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab

Therapeutic advances in neurological disorders, 2019, Vol.12, p.1756286419887596-1756286419887596

2019

Volltextzugriff (PDF)

Neurological management and work-up of neurotoxicity associated with CAR T cell therapy

Neurological research and practice, 2022-01, Vol.4 (1), p.1-1, Article 1

2022

Volltextzugriff (PDF)

Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241253917

2024

Volltextzugriff (PDF)

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity

Cancer medicine (Malden, MA), 2023-04, Vol.12 (8), p.9373-9383

2023

Volltextzugriff (PDF)

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid

Journal of Central Nervous System Disease, 2021, Vol.13, p.11795735211042166-11795735211042166

2021

Volltextzugriff (PDF)

Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy

Fluids and barriers of the CNS, 2020-10, Vol.17 (1), p.65-65, Article 65

2020

Volltextzugriff (PDF)

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

Fluids and barriers of the CNS, 2019-09, Vol.16 (1), p.28-28, Article 28

2019

Volltextzugriff (PDF)

The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic

Biomolecules (Basel, Switzerland), 2021-09, Vol.11 (9), p.1372

2021

Volltextzugriff (PDF)

18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma

Annals of nuclear medicine, 2021, Vol.35 (1), p.132-138

2021

Volltextzugriff (PDF)

The Influence of the Ventricular-Lumbar Gradient on Cerebrospinal Fluid Analysis in Serial Samples

Brain sciences, 2022-03, Vol.12 (3), p.410

2022

Volltextzugriff (PDF)

Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications

Cells (Basel, Switzerland), 2022-07, Vol.11 (14), p.2165

2022

Volltextzugriff (PDF)

Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients

Brain sciences, 2021-02, Vol.11 (3), p.296

2021

Volltextzugriff (PDF)

Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway

Annals of clinical and translational neurology, 2021-12, Vol.8 (12), p.2228-2234

2021

Volltextzugriff (PDF)

Diagnose und Therapie der Multiplen Sklerose

Neurologie up2date, 2022-12, Vol.5 (4), p.292-300

2022

Volltextzugriff (PDF)

Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome

Journal of critical care, 2020-06, Vol.57, p.124-129

2020

Volltextzugriff (PDF)

Progressive multifokale Leukenzephalopathie: Diagnostik und Therapieoptionen

Neuroradiologie Scan, 2024-10, Vol.14 (4), p.287-298

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(62)
Berichte
(2)

Sprache

Englisch
(58)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy

Editorial: Autoimmune complications of modern cancer therapies

Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation

The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis

PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics

Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients

Brief research report: in-depth immunophenotyping reveals stability of CD19 CAR T-cells over time

Therapy with cladribine is efficient and safe in patients previously treated with natalizumab

Neurological management and work-up of neurotoxicity associated with CAR T cell therapy

Combined treatment with allogeneic Epstein-Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report

Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor‐associated neurotoxicity

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid

Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy

Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic

18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma

The Influence of the Ventricular-Lumbar Gradient on Cerebrospinal Fluid Analysis in Serial Samples

Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications

Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients

Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway

Diagnose und Therapie der Multiplen Sklerose

Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome

Progressive multifokale Leukenzephalopathie: Diagnostik und Therapieoptionen

Suchergebnisse filtern